• Wadi El Haj 13 - Nazareth, Israel
  • peter@intra-gel.com


INTRAGEL’s novel technology features a pre-filled ready to use syringe which is for direct intra-tumoral application. The syringe contains an anti-cancer drug formulated into a de-novo gel-like, hydrophobic, biocompatible and biodegradable polymer that slowly releases the drug into the tumor over a few weeks with minimal systemic toxicity and maximum safety.

  • INTRAGEL’s technology can be applied to a wide range of anti-cancer drugs and is suitable for various types of solid tumors.
  • INTRAGEL’s technology is protected by a patent application.
  • INTRAGEL has so-far achieved excellent pre-clinical results.

INTRAGEL is a science-based company engaged in developing an innovative, state-of-the-art treatment for solid tumors based on an intra-tumoral injectable deliver system with extended release of anticancer drugs.

Contact Info

  • Nazareth Industrial Area Wadi El Haj 13 P.O.Box 1252 Nazareth, 17111 Israel
  • +972-4-6098606